Editorial: The microbiome in the development of gastrointestinal diseases

Editorial: The microbiome in the development of gastrointestinal diseases

Detalles Bibliográficos
Main Authors:	Amedeo Amedei, Ralf Weiskirchen
Formato:	Artigo
Idioma:	English
Publicado:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	microbiome gastrointestinal disease MAFLD inflammatory bowel disease colorectal cancer dysbiosis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fcimb.2025.1561143/full

Títulos similares

The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
por: Sheng Liu, et al.
Publicado: (2020-06-01)

The intestinal microbiome of inflammatory bowel disease across the pediatric age range
por: Máire A. Conrad, et al.
Publicado: (2024-12-01)

The microbiome landscape in pediatric Crohn’s disease and therapeutic implications
por: Karin Fetter, et al.
Publicado: (2023-12-01)

Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC)
por: Edda Russo, et al.
Publicado: (2023-05-01)

Dietary Regulation of the Crosstalk between Gut Microbiome and Immune Response in Inflammatory Bowel Disease
por: Qianqian Yao, et al.
Publicado: (2021-02-01)

Pathogenic role of the gut microbiota in gastrointestinal diseases
por: Hiroko Nagao-Kitamoto, et al.
Publicado: (2016-04-01)

Editorial: Understanding molecular mechanisms to facilitate the development of biomarkers for therapeutic intervention in gastrointestinal diseases and sepsis
por: Dipak Kumar Sahoo, et al.
Publicado: (2025-03-01)

The effects of dairy on the gut microbiome and symptoms in gastrointestinal disease cohorts: a systematic review
por: Clíona Ní Chonnacháin, et al.
Publicado: (2024-01-01)

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease
por: Cinzia Parolini, et al.
Publicado: (2020-12-01)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
por: Khalid Elmaghrawy, et al.
Publicado: (2021-01-01)

Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
por: Helal F. Hetta, et al.
Publicado: (2024-10-01)

The Human Gut Microbiome – A Potential Controller of Wellness and Disease
por: Zhi Y. Kho, et al.
Publicado: (2018-08-01)

Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease
por: Hengameh Chloé Mirsepasi-Lauridsen, et al.
Publicado: (2018-11-01)

Hydrogen Sulfide Effects on the Survival of Lactobacilli with Emphasis on the Development of Inflammatory Bowel Diseases
por: Ivan Kushkevych, et al.
Publicado: (2019-11-01)

Genetic and causal relationship between chronic gastrointestinal diseases and erectile dysfunction: a Mendelian randomization study
por: Xiaoyan Zeng, et al.
Publicado: (2024-07-01)

D-Lactate: Implications for Gastrointestinal Diseases
por: Barblin Remund, et al.
Publicado: (2023-05-01)

Ghrelin in Focus: Dissecting Its Critical Roles in Gastrointestinal Pathologies and Therapies
por: Wei Wu, et al.
Publicado: (2024-01-01)

Gastrointestinal microbiome and coronavirus disease: evidence of a bidirectional association
por: Kevin V. Houston, et al.
Publicado: (2023-04-01)

Gastrointestinal Tuberculosis Mimicking Crohn’s Disease
por: Maria Ana Rafael, et al.
Publicado: (2019-12-01)

Gastrointestinal microbiome, what is behind faecal microbiota transplantation?
por: P. Thomson, et al.
Publicado: (2021-07-01)

Microbiome, Metabolome and Inflammatory Bowel Disease
por: Ishfaq Ahmed, et al.
Publicado: (2016-06-01)

The Reg protein family: potential new targets for the treatment of inflammatory bowel disease and colorectal cancer
por: Anqi Yao, et al.
Publicado: (2024-09-01)

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity
por: P. R. Sternes, et al.
Publicado: (2022-07-01)

CORRELATION BETWEEN IBD, INTESTINAL DYSBIOSIS, DIET AND MOOD TONE DISEASE: ANALYSIS OF LITERATURE
por: Giorgio Maida
Publicado: (2022-12-01)

Homeostasis and Dysbiosis of the Intestinal Microbiota: Comparing Hallmarks of a Healthy State with Changes in Inflammatory Bowel Disease
por: Jasminka Talapko, et al.
Publicado: (2022-12-01)

Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance
por: Lavinia Curini, et al.
Publicado: (2021-09-01)

Editorial: Epigenetics of inflammatory reactions and pharmacological modulation
por: Amedeo Amedei, et al.
Publicado: (2024-10-01)

Emerging trends and research foci in gastrointestinal microbiome
por: Xiaoquan Huang, et al.
Publicado: (2019-02-01)

Editorial: Reviews in microbiome in health & disease
por: Suhana Chattopadhyay, et al.
Publicado: (2024-05-01)

The oral microbiome and oral and upper gastrointestinal diseases
por: Sifan Liu, et al.
Publicado: (2024-12-01)

Pollutants, microbiota and immune system: frenemies within the gut
por: Pierluigi Rio, et al.
Publicado: (2024-05-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
por: Z. A. Mamieva, et al.
Publicado: (2022-01-01)

Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
por: Michal Lubomski, et al.
Publicado: (2022-05-01)

MAIT cells and the microbiome
por: Maisha F. Jabeen, et al.
Publicado: (2023-02-01)

Role of human microbiota in the development of colorectal cancer
por: S. O. Kochkina, et al.
Publicado: (2019-10-01)

Gut microbiota therapy in gastrointestinal diseases
por: Hanif Ullah, et al.
Publicado: (2025-02-01)

Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
por: Phillipp Hartmann, et al.
Publicado: (2022-04-01)

Molecular mechanisms of intestinal inflammation leading to colorectal cancer
por: Sonia Shastri, et al.
Publicado: (2017-02-01)

Studying the Enteric Microbiome in Inflammatory Bowel Diseases: Getting through the growing pains and moving forward
por: Vincent B Young, et al.
Publicado: (2011-07-01)

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
por: Erica Jennison, et al.
Publicado: (2021-01-01)